79 related articles for article (PubMed ID: 19153211)
1. Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models.
Festuccia C; Gravina GL; D'Alessandro AM; Muzi P; Millimaggi D; Dolo V; Ricevuto E; Vicentini C; Bologna M
Endocr Relat Cancer; 2009 Jun; 16(2):401-13. PubMed ID: 19153211
[TBL] [Abstract][Full Text] [Related]
2. Growth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G
Lee E; Decker AM; Cackowski FC; Kana LA; Yumoto K; Jung Y; Wang J; Buttitta L; Morgan TM; Taichman RS
J Cell Biochem; 2016 Dec; 117(12):2815-2824. PubMed ID: 27153245
[TBL] [Abstract][Full Text] [Related]
3. [Effects of Qilan Prescription on the proliferation and apoptosis of human prostate cancer DU145 cells and its action mechanism].
Zhou J; Yuan F; Luo CM; Zhu K; Liu BY; Chang Y; You YD
Zhonghua Nan Ke Xue; 2023 Mar; 29(3):255-263. PubMed ID: 38597708
[TBL] [Abstract][Full Text] [Related]
4. Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G1-S Transition.
Buck SAJ; Van Hemelryk A; de Ridder C; Stuurman D; Erkens-Schulze S; van 't Geloof S; Teubel WJ; Koolen SLW; Martens-Uzunova ES; van Royen ME; de Wit R; Mathijssen RHJ; van Weerden WM
Mol Cancer Ther; 2024 May; 23(5):711-720. PubMed ID: 38030379
[TBL] [Abstract][Full Text] [Related]
5. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer.
Malik A; Afaq F; Sarfaraz S; Adhami VM; Syed DN; Mukhtar H
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14813-8. PubMed ID: 16192356
[TBL] [Abstract][Full Text] [Related]
6. Repurposing screen identifies mebendazole as a clinical candidate to synergise with docetaxel for prostate cancer treatment.
Rushworth LK; Hewit K; Munnings-Tomes S; Somani S; James D; Shanks E; Dufès C; Straube A; Patel R; Leung HY
Br J Cancer; 2020 Feb; 122(4):517-527. PubMed ID: 31844184
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of roburic acid in combination with docetaxel on human prostate cancer cells.
Wang X; Xuetao X; Wu M; Wu P; Sheng Z; Liu W; Ma YY; Zhao DG; Zhang K; Li D; Zheng X; Goodin S
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):542-553. PubMed ID: 34986722
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin Enhances Effects of Radiotherapy on Prostate Cancer Cells and Xenograft Tumor Mice Through Triggering Interaction Between Bcl-2 and MSH2.
He Z; Yuan J; Shen F; Zeng F; Qi P; Wang Z; Zhai Z
Med Sci Monit; 2020 Sep; 26():e923560. PubMed ID: 32870824
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of paclitaxel cytotoxicity by inostamycin in human small cell lung carcinoma, Ms-1 cells.
Simizu S; Tanabe K; Tashiro E; Takada M; Umezawa K; Imoto M
Jpn J Cancer Res; 1998 Sep; 89(9):970-6. PubMed ID: 9818034
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma.
Baldi A; Piccolo MT; Boccellino MR; Donizetti A; Cardillo I; La Porta R; Quagliuolo L; Spugnini EP; Cordero F; Citro G; Menegozzo M; Calogero RA; Crispi S
PLoS One; 2011; 6(8):e23569. PubMed ID: 21858171
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Ribonucleotide Reductase Induces Endoplasmic Reticulum Stress and Apoptosis, Leading to the Death of Docetaxel-resistant Prostate Cancer Cells.
Serttas R; Erdogan S
Anticancer Agents Med Chem; 2023; 23(17):1958-1965. PubMed ID: 37565554
[TBL] [Abstract][Full Text] [Related]
12. Increasing the radiation-induced cytotoxicity by silver nanoparticles and docetaxel in prostate cancer cells.
Hatami Zharabad S; Mohammadian M; Zohdi Aghdam R; Hassanzadeh Dizaj M; Behrouzkia Z
Mol Biol Rep; 2024 May; 51(1):633. PubMed ID: 38724835
[TBL] [Abstract][Full Text] [Related]
13. Adenoviral-mediated pHyde gene transfer and cisplatin additively inhibit human prostate cancer growth by enhancing apoptosis.
Lu Y; Zhang X; Beheshti B; Zhang J
Prostate; 2009 Feb; 69(3):234-48. PubMed ID: 19016247
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of docetaxel combined with a novel multi-target inhibitor CUDC-101 on inhibiting human prostate cancer.
Li Z; Quan C; Li W; Ji M
Pathol Res Pract; 2023 Dec; 252():154938. PubMed ID: 37989076
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a small molecule that inhibits Bcl-3-mediated cyclin D1 expression in melanoma cells.
Saamarthy K; Ahlqvist K; Daams R; Balagunaseelan N; Rinaldo-Matthis A; Kazi JU; Sime W; Massoumi R
BMC Cancer; 2024 Jan; 24(1):103. PubMed ID: 38238702
[TBL] [Abstract][Full Text] [Related]
16. Combination of navitoclax (Bcl-2 and Bcl-xL inhibitor) and Debio-0932 (Hsp90 inhibitor) suppresses the viability of prostate cancer cells via induction of apoptotic signaling pathway.
Asdemir A; Özgür A
Med Oncol; 2024 Mar; 41(4):83. PubMed ID: 38436810
[TBL] [Abstract][Full Text] [Related]
17. Integrated aerobic exercise with LDE-docetaxel treatment: a novel approach to combat prostate cancer progression.
Veras ASC; Batista VRG; Correia RR; de Almeida Tavares ME; Rubira RJG; Tavares ER; Giometti IC; Maranhão RC; Teixeira GR
Sci Rep; 2024 Apr; 14(1):9626. PubMed ID: 38671015
[TBL] [Abstract][Full Text] [Related]
18. Treatment with 5-azacitidine delay growth of glioblastoma xenografts: a potential new treatment approach for glioblastomas.
Kratzsch T; Kuhn SA; Joedicke A; Hanisch UK; Vajkoczy P; Hoffmann J; Fichtner I
J Cancer Res Clin Oncol; 2018 May; 144(5):809-819. PubMed ID: 29427211
[TBL] [Abstract][Full Text] [Related]
19. 5-Azacitidine restores and amplifies the bicalutamide response on preclinical models of androgen receptor expressing or deficient prostate tumors.
Gravina GL; Marampon F; Di Staso M; Bonfili P; Vitturini A; Jannini EA; Pestell RG; Tombolini V; Festuccia C
Prostate; 2010 Aug; 70(11):1166-78. PubMed ID: 20333699
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in understanding DNA methylation of prostate cancer.
Shin HJ; Hua JT; Li H
Front Oncol; 2023; 13():1182727. PubMed ID: 37234978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
